We are live on
!
Find out more
KWMG
King Wealth Management Group Portfolio holdings
AUM
$800M
1-Year Est. Return
22.41%
This Fund
S&P 500
This Quarter
Est. Return
-3.88%
1 Year Est. Return
+22.41%
3 Year Est. Return
+75.43%
5 Year Est. Return
+92.87%
10 Year Est. Return
+325.86%
AUM
$660M
AUM Growth
-$25.8M
(-3.8%)
Cap. Flow
+$8.09M
Cap. Flow
% of AUM
1.23%
Top 10 Holdings %
Top 10 Hldgs %
54.81%
Holding
164
New
10
Increased
66
Reduced
57
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$2.87M |
| 2 |
Oracle
ORCL
|
+$2.35M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.16M |
| 5 |
HOLX
Hologic
HOLX
|
+$1.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$1.51M |
| 2 |
Zimmer Biomet
ZBH
|
+$963K |
| 3 |
iShares US Healthcare Providers ETF
IHF
|
+$960K |
| 4 |
Stevanato
STVN
|
+$763K |
| 5 |
Eli Lilly
LLY
|
+$626K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.86% |
| 2 | Financials | 9.27% |
| 3 | Healthcare | 8.42% |
| 4 | Consumer Staples | 5.18% |
| 5 | Consumer Discretionary | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AWF
151
AllianceBernstein Global High Income Fund
AWF
$869M
| $204K | 0.03% |
19,000
+4,000
| +27% | +$43.3K |
|
152
WD-40
WDFC
$2.98B
| $203K | 0.03% |
831
-29
| -3% | -$6.85K |
|
|
ETB
153
Eaton Vance Tax-Managed Buy-Write Income Fund
ETB
$444M
| $184K | 0.03% |
13,463
-1,472
| -10% | -$21.5K |
|
154
KeyCorp
KEY
$23.8B
| $164K | 0.02% |
10,277
+16
| +0.2% | +$271 |
|
155
Viatris
VTRS
$20.8B
| $113K | 0.02% |
+12,946
| New | +$136K |
|
156
Heron Therapeutics
HRTX
$93.4M
| $59K | 0.01% |
26,799
| – | – |
|
|
DFTX
157
Definium Therapeutics
DFTX
$5.6B
| $59K | 0.01% |
10,000
| – | – |
|
158
Aldeyra Therapeutics
ALDX
$97.1M
| – | – |
-13,500
| Closed | -$67K |
|
159
Ametek
AME
$53.9B
| – | – |
-1,365
| Closed | -$246K |
|
160
Bank of America
BAC
$429B
| – | – |
-4,706
| Closed | -$207K |
|
|
161
iShares US Healthcare Providers ETF
IHF
$1.22B
| – | – |
-20,000
| Closed | -$960K |
|
162
Lazard
LAZ
$4B
| – | – |
-4,500
| Closed | -$232K |
|
|
NVO
163
Novo Nordisk
NVO
$228B
| – | – |
-2,379
| Closed | -$205K |
|
|
164
Stevanato
STVN
$5.57B
| – | – |
-35,000
| Closed | -$763K |
|
Similar funds
HP
CG
LWM
NW
IAM
GWA
AAM
1IA
King Wealth Management Group's Q1 2025 Portfolio in Review
As of Q1 2025, King Wealth Management Group held 164 positions worth $660M, down 3.8% from $686M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
King Wealth Management Group's Q1 2025 filing shows 10 new, 66 increased, 57 reduced and 7 closed positions. Its largest new stake was Tenet Healthcare: 5,500 shares worth $740K. The largest sale was Cigna, an estimated $1.51M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
- King Wealth Management Group's largest Q1 2025 buy was Tenet Healthcare: 5,500 shares worth $740K.
- King Wealth Management Group added most to Teva Pharmaceuticals in Q1 2025, an estimated $2.87M increase.
- King Wealth Management Group's biggest Q1 2025 reduction was Cigna, cutting an estimated $1.51M.
- King Wealth Management Group fully exited iShares US Healthcare Providers ETF in Q1 2025, selling an estimated $960K.
- King Wealth Management Group's ten largest holdings make up 55% of its $660M portfolio in Q1 2025.
- King Wealth Management Group opened 10 new positions and closed 7 in Q1 2025.
- King Wealth Management Group's portfolio value fell 3.8% quarter-over-quarter to $660M.
Based on King Wealth Management Group's 13F filing for Q1 2025, filed 8 May 2025.